OP Asset Management’s United Therapeutics UTHR Stock Holding History

OP Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.54M	Buy	4,694 +106	+2%	+$59.7K	0.03%	406
2026 Q1	$2.72M	Sell	4,588 -254	-5%	-$126K	0.03%	374
2025 Q4	$2.36M	Sell	4,842 -874	-15%	-$407K	0.03%	398
2025 Q3	$2.4M	Buy	5,716 +874	+18%	+$294K	0.03%	398
2025 Q2	$1.39M	Buy	4,842 +415	+9%	+$124K	0.02%	547
2025 Q1	$1.36M	Buy	+4,427	New	+$1.52M	0.02%	539

Other funds holding UTHR

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

AIM

Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

OP Asset Management's UTHR Position: Q2 2026 in Review

OP Asset Management increased its United Therapeutics (UTHR) stake by 2.3% in Q2 2026, buying an estimated $59.7K and bringing the position to 4,694 shares worth $2.54M. The position accounts for 0.03% of the portfolio, ranked #406.

OP Asset Management first reported a position in UTHR in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.72M in Q1 2026. 219 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

OP Asset Management held 4,694 shares of United Therapeutics worth $2.54M as of Q2 2026.
OP Asset Management bought 106 United Therapeutics shares in Q2 2026, an estimated $59.7K.
United Therapeutics made up 0.03% of OP Asset Management's portfolio in Q2 2026, its #406 holding.
OP Asset Management first reported a position in United Therapeutics in Q1 2025 and has held it in 6 quarters since.
OP Asset Management's United Therapeutics position peaked at $2.72M in Q1 2026.
219 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.